id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0150-0019,FDA,FDA-2008-D-0150,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims",Notice,Notice of Approval,2013-12-19T05:00:00Z,2013,12,2013-12-19T05:00:00Z,,2013-12-19T17:20:33Z,2013-30146,0,0,09000064814cb007
FDA-2008-D-0150-0018,FDA,FDA-2008-D-0150,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims,Notice,General Notice,2013-08-22T04:00:00Z,2013,8,2013-08-22T04:00:00Z,2013-09-24T03:59:59Z,2013-08-22T14:23:12Z,2013-20471,0,0,09000064813bf008
FDA-2008-D-0150-0017,FDA,FDA-2008-D-0150,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims,Notice,General Notice,2013-04-18T04:00:00Z,2013,4,2013-04-18T04:00:00Z,2013-06-18T03:59:59Z,2014-01-14T13:21:01Z,2013-09093,0,0,0900006481299b1d